Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxaliplatin and 5-FU Based Preoperative Chemoradiation in Rectal Cancer
NCT00278694Phase 2Completed
- Sponsor
- Oslo University Hospital
- Start
- Sep 2005
- Primary completion
- Feb 2016
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of oxaliplatin, fluorouracil in rectal cancer, sponsored by Oslo University Hospital. Started Sep 2005; status: completed.
02
Drugs
oxaliplatinfluorouracil
03
Conditions
rectal cancer
Beyond the preview
Go deeper on NCT00278694.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00278694.